Global searching is not enabled.
Skip to main content
Book

THE DIAGNOSIS, TREATMENT, AND PREVENTION OF THROMBOSIS IN PAEDIATRIC AGE GROUPS

Completion requirements
"last update: 6 March  2025"                                                                                                          Download Guideline

- Scope and Purpose

➡️Disease/Condition:

Thrombosis in different pediatric age groups.

➡️Guideline Objectives

To Provide an evidence-based document for the

1. Identification of neonates, infants, children, and adolescents at high risk of thrombosis.

2. Diagnostic approaches in the target population.

3. Management of thrombosis in the target population. 

4.  Prevention of thrombosis in the target population

Health / Clinical Question (PIPOH)

 

P: Patient (Target Population):

 

•Gender: Both genders.

• Age group: Neonates, Infants, children & adolescents less than 18 years.

•  Disease/ Condition: thrombosis (arterial/venous,  site, disease categories).

•  Exclusion criteria: thrombotic microangiopathy,  disseminated intravascular coagulopathy, thrombosis due to stasis and/ or blood vessel injury.

I: Interventions and Practices Considered / CPG Category:

 

Diagnosis:

• Venous thrombosis

•  Arterial thrombosis

Treatment

•  Venous thrombosis

• Arterial thrombosis

Prevention

P: Professionals (Intended / Target Users or Stakeholders)   :

 

Primary health care physicians at the Ministry of Health, general practitioners, family medicine specialists, pediatricians, hematologists, oncologists, neonatologists, intensive care specialists, surgeons, neurologists, nurses, and medical students.

O: Major Outcomes Considered:

 

•  Primary outcome:

Prevent mortality and morbidity from thrombosis.

- Prevent sequelae and disabilities

•  Secondary outcome:

Family counseling

Prevention of recurrence

H: Healthcare Settings:

 

Primary, secondary, and tertiary healthcare services mainly outpatient clinics and emergency rooms in governmental, non-governmental and private sectors in Egypt.

 

Guidelines 1-5 used the Grading of Recommendations Assessment Development and Evaluation (GRADE) methodology18.Guideline 6 used an early version of GRADE. 

Rating Scheme for the Strength of the Evidence/Recommendations:

➡️GRADE ranking of evidence

High

Further research is very unlikely to change our confidence in the estimate of effect

Moderate

Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.

Low

Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.

Very low

Any estimate of effect is very uncertain.

GRADE Ratings for Recommendations For or Against Practice

Strong

the panel is confident that the desirable effects of adherence to a recommendation outweigh the unesirable effects

conditional

the panel concludes that the desirable effects of adherence to a recommendation probably outweigh the undesirable effects, but is not confident.

 

➡️Good practice statement refers to

Good practice statements represent recommendations that the Guidelines Development Group (GDG) feels are important, although they are not adequate for a formal certainty of evidence rating according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) working group.